Research | Behavioral Healthcare Executive Skip to content Skip to navigation

Research

Annual cost of opioid crisis as high as $504 billion

November 21, 2017  |  Julie Miller, Editor in Chief
article

Two recent research studies have placed dollar amounts on the staggering costs of opioid addiction and overdose deaths. One federal report puts the cost at $504 billion.

Medicare places few restrictions on opioid prescribing

October 16, 2017  |  Tom Valentino, Senior Editor
article

A study released by researchers at Yale University shows one-third of opioid medications were prescribed with no limitations from Medicare plans.

Complex presentation a challenge for treating veterans

August 8, 2017  |  Tom Valentino, Senior Editor
article

A study conducted by Cigna healthcare finds practitioners believe treating veterans with opioid use disorder is more challenging than treating civilians, and many feel they could benefit from more staff with direct experience. 

FACT FILE: High dosages linked to surge in opioid use disorder

June 30, 2017  |  Tom Valentino, Senior Editor
news

A Blue Cross Blue Shield Association study of members in its commercial plans found high-dosage opioid prescriptions were linked with higher rates of opioid use disorder diagnoses.

Opioid-related treatment approaches vary by region

June 14, 2017  |  Tom Valentino, Senior Editor
article

Data released this week by not-for-profit FAIR Health shows significant variation in treatment approaches for opioid-related diagnoses by location.

SAMHSA: Medication treatment for SUD increases significantly

June 12, 2017  |  Julie Miller, Editor in Chief
article

According to SAMHSA’s latest Behavioral Health Barometer, between 2011 and 2015, methadone use increased by 16%, and use of buprenorphine more than doubled.

Need for buprenorphine demonstrated in Medicaid data

June 7, 2017  |  Julie Miller, Editor in Chief
article

A new brief from the Urban Institute shows that Medicaid programs nationwide have seen increases in buprenorphine prescriptions since the launch of the Affordable Care Act, but trends are higher in expansion states.

D.C. fares worst in drug-related issues

May 15, 2017  |  Julie Miller, Editor in Chief
article

Personal-finance website WalletHub distilled 15 different measures into state rankings and found the District of Columbia has the highest prevalence of drug-related issues.

First responders leery of seeking mental health help

May 1, 2017  |  Tom Valentino, Senior Editor
article

According to a survey released by the University of Phoenix College of Social Sciences, 39% of first responders say they do not feel comfortable talking to their supervisors about their mental health, and the same number feel there are repercussions for...

Payers prefer objective data on mental health medications

April 14, 2017  |  Tom Valentino, Senior Editor
news

Many mental health advocacy groups push for greater input from patients in clinical trials, but new research shows payers are more interested in objective data that measures new medications’ effectiveness.

NAATP releases initial data from outcomes project

April 6, 2017  |  Gary A. Enos, Contributing Editor
article

Initial results from the National Association of Addiction Treatment Providers' Outcomes Pilot Program show a patient population with past experience in treatment and significant mental health concerns.

Shelton named CEO of Centerstone Research Institute

March 31, 2017  |  David Raths
article

Researcher and educator Richard Shelton, MD, has been named chief medical officer of Centerstone and CEO of its Centerstone Research Institute.

Pages

Subscribe to Research